Page last updated: 2024-08-23

azimexon and Breast Neoplasms

azimexon has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mathe, G	1
Boerner, D; Kreienberg, R; Lemmel, EM; Melchert, F	1
Blijham, G; Dittrich, D; Jakesz, R; Rainer, H; Reiner, A; Reiner, G; Reynders, M; Schemper, M; Schutte, B; Spona, J	1

Reviews

1 review(s) available for azimexon and Breast Neoplasms

Article	Year
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants. Comparative immunology, microbiology and infectious diseases, 1980, Volume: 3, Issue:4 Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin	1980

Article

Year

Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.

Comparative immunology, microbiology and infectious diseases, 1980, Volume: 3, Issue:4

Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin

1980

Trials

1 trial(s) available for azimexon and Breast Neoplasms

Article	Year
Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 115 Topics: Antineoplastic Combined Chemotherapy Protocols; Aziridines; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Mastectomy; Menopause; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Rate; Vincristine	1989

Article

Year

Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 115

Topics: Antineoplastic Combined Chemotherapy Protocols; Aziridines; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Mastectomy; Menopause; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Rate; Vincristine

1989

Other Studies

1 other study(ies) available for azimexon and Breast Neoplasms

Article	Year
Reduction of the immunosuppressive action of chemotherapeutics in patients with mammary carcinoma by Azimexon. Journal of immunopharmacology, 1983, Volume: 5, Issue:1-2 Topics: Aziridines; Azirines; B-Lymphocytes; Breast Neoplasms; Cells, Cultured; Female; Humans; Immunosuppression Therapy; Leukocyte Count; Lymphocyte Activation; T-Lymphocytes	1983